Jupiter Neurosciences (JUNS)

• Market cap: $55.4M
• 1 day: -2.45%
• 5 days: 3.92%
• 1 month: 6.71%
• 3 months: -7.56%
• 6 months: 156.45%
• Year to date: -84.84%
• 1 year: -71.04%
• 5 years: -71.04%
• 10 years: -71.04%
• Sector: Healthcare
• Industry: Biotechnology

About: Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Employees: 4